Vasuk Gautam | Bioinformatics | Best Researcher Award

Dr. Vasuk Gautam | Bioinformatics | Best Researcher Award

Sr.Scientist | Norton Research Institute | United States

Dr. Vasuk Gautam is an emerging researcher whose work spans metabolomics, biomarker discovery, and computational methods for enhancing analytical confidence in high-throughput biological studies. With a record of 24 peer-reviewed publications, 13 h-index and over 3,102 citations, Gautam has established a strong early-career footprint marked by methodological innovation and extensive interdisciplinary collaboration. His contributions focus particularly on developing frameworks for improving metabolite identification accuracy—an essential challenge in metabolomics that directly influences the reliability of biomedical and environmental research. Notably, his recent work introducing the concept of “Identification Probability” provides a transferable, automated metric for evaluating identification confidence, positioning it as a potentially transformative tool for large-scale metabolomic pipelines. In parallel, Gautam has contributed significantly to the development of MarkerDB 2.0, a comprehensive biomarker database that integrates molecular, clinical, and contextual information to support precision medicine, translational research, and global health initiatives. His scholarship reflects a blend of computational rigor, domain expertise, and a commitment to open-access scientific resources. Gautam’s collaborations include partnerships with over 180 co-authors, underscoring his active engagement with diverse research groups and his ability to contribute meaningfully to multi-institutional projects. This collaborative network spans biochemistry, bioinformatics, systems biology, and clinical sciences, highlighting the broad applicability and relevance of his expertise. Through both his methodological contributions and his involvement in global data-resource efforts, Gautam’s work supports reproducibility, accessibility, and evidence-based discovery in molecular life sciences. His growing citation impact and participation in influential open-access initiatives demonstrate both scientific merit and societal relevance, particularly in areas related to disease diagnostics, personalized healthcare, and data-driven research infrastructures.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., … (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622–D631.

Cited by: 2116

2. Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., … (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265–D1275.

Cited by: 1112

3. Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., … (2023). PHASTEST: Faster than PHASTER, better than PHAST. Nucleic Acids Research, 51(W1), W443–W450.

Cited by: 394

4. Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., … (2022). BioTransformer 3.0: A web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123.

Cited by: 160

5. Wang, F., Allen, D., Tian, S., Oler, E., Gautam, V., Greiner, R., Metz, T. O., … (2022). CFM-ID 4.0: A web server for accurate MS-based metabolite identification. Nucleic Acids Research, 50(W1), W165–W174.

Cited by: 115

Dr. Vasuk Gautam’s work advances the reliability and scalability of metabolomic and biomarker research, enabling more accurate diagnostics and deeper biological insight. By developing robust identification metrics and contributing to global data resources, he helps accelerate scientific discovery, support precision medicine, and enhance evidence-based decision-making across research, healthcare, and industry.

Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Dr. Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Lab Manager | Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh is a distinguished molecular and cellular biologist and the Founder and Director of Zist Fanavari Novin Biotechnology Institute in Isfahan, Iran. With over two decades of leadership in academia, research, and biotechnology entrepreneurship, she has significantly advanced cancer genomics, gene expression analysis, and personalized medicine. Her research spans diverse areas including breast cancer, cardiovascular disease, multiple sclerosis, drug resistance, and athletic genomics. In 2023, she founded PreventiGene, a genetics startup focused on early cancer detection. Dr. Azadeh has served as Chair of the Board at Control Tavan Novin Pouya since 2006, and has also managed the COVID-19 department at Jey Medical Diagnosis Laboratory. An active educator, she has taught for 20 semesters at Azad University and leads national technical training programs in biotechnology. She has authored books on laboratory methods and cancer diagnostics, serves as an editor for medical journals, and regularly collaborates with academic and industry partners to promote scientific innovation. She is widely recognized for her expertise in advanced technologies such as CRISPR, RNA sequencing, and high-throughput data analysis, and has developed and supervised numerous genetic research initiatives. Her technical skills span PCR/qPCR, ELISA, Western blotting, microbiology, and cell culture. As of October 2025, Dr. Azadeh has authored 34 indexed publications, with 313 citations, and holds an h-index of 13 , reflecting her impactful contribution to life sciences and translational research.

Profiles: Scopus | Google Scholar | LinkedIn | ResearchGate

Featured Publications

1. Bagheri, F., Mesrian Tanha, H., Mojtabavi Naeini, M., Ghaedi, K., & Azadeh, M. (2016). Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4. Molecular Medicine Reports, 13(5), 4494–4498. 
Cited by: 39

2. Ebrahimi Ghahnavieh, L., Tabatabaeian, H., Ebrahimi Ghahnavieh, Z., & others. (2020). Fluctuating expression of miR-584 in primary and high-grade gastric cancer. BMC Cancer, 20, 621. 
Cited by: 31

3. Noormohammad, M., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Talebi, A., & others. (2016). Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. Journal of Genetics, 95(4), 991–995. 
Cited by: 29

4. Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., & others. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Human Cell, 33(4), 1229–1239.
Cited by: 28

5. Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics, 15(1), 108–114.
Cited by: 28